Sanofi will soon commence a Phase I/II trial with its vaccine candidate to start generating immunogenicity data.

Living a healthy life means knowing the symptoms of chlamydia and taking the necessary precautions under a doctor's guidance.

Sanofi’s mRNA vaccine candidate for chlamydia has been granted fast track designation by the US FDA, reflecting its promising potential to addr ...

Get Instant Summarized Text (Gist) Chlamydia trachomatis forms protective inclusions by fusing their membranes to create large bacterial pockets inside human cells. This fusion process involves ...

The following is a summary of “Diagnostic-avoiding Chlamydia trachomatis variants detected in cervical and endometrial ...

Chlamydia is an infection caused by the bacterium Chlamydia trachomatis. It's one of the most widespread of all sexually transmitted diseases, according to the Centers for Disease Control and ...

Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...

Various steps have been adopted by the health ministry under the National Programme for Control of Blindness and Visual ...

The bacteria behind chlamydia can colonize the gut, and from that hiding place, they may act as a source of repeated ...

The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. The decision was based on the potential of the ...

Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infer ...